Amendment to Schedule 13D for Rani Therapeutics Holdings, Inc.

This Amendment No. 1 to Schedule 13D, filed by Mir Imran and InCube Labs, L.L.C., updates the ownership details of Class A Common Stock of Rani Therapeutics Holdings, Inc. The amendment includes the purchase of 2,083,334 shares of Class A Common Stock and 2,083,334 warrants by Mir Imran in a private placement on October 23, 2025. The total purchase price was $1,260,417.07, funded by personal funds. The amendment also details changes to the Issuer's Amended and Restated Certificate of Incorporation, including reducing the voting power of Class B Common Stock and eliminating the ability of stockholders to act by written consent. The Reporting Persons collectively own shares representing a majority of the outstanding voting power and intend to vote in favor of the proposed changes.